Global disease experts say little is known about China's experience with long-term COVID effects thought to have afflicted millions with debilitating fatigue, brain fog and other symptoms
Pfizer to spend $120m to boost US COVID pill manufacturing
Pfizer Inc said on Monday it would spend $120 million to expand manufacturing of its COVID-19 antiviral treatment at its Michigan plant, as demand ramps up.
Published : 6 June 2022, 04:25 PM
Updated : 6 June 2022, 04:25 PM
Use of the pill, Paxlovid, authorised to treat newly infected, at-risk people to prevent severe illness, has soared recently as infections rise.
Biden administration officials have pushed for the wider use of Paxlovid, which the government distributes for free.
RELATED STORIES
The demonstrations helped to end COVID restrictions but failed to achieve lasting political change, six participants based in China and overseas say
The agency seeks details on an increase in respiratory illnesses and reported clusters of pneumonia in children, which its China office called a ‘routine’ check
The inquiry is examining the government's response to the coronavirus pandemic that shut large sections of the economy and killed more than 220,000 people in Britain
